Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Conference News TCT 2025

What Makes MedTech Great—or Not—and Envisioning Its Future

Caitlin E. Cox

November 04, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

Presentation TCT 2022

Moving Beyond Pharmacotherapy: The Transformative Role of Devices in HF Treatment

Presenter: William Abraham

September 16, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

News Conference News TCT 2021

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Yael L. Maxwell

November 09, 2021

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News Conference News TCT 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Michael O'Riordan

October 17, 2020

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

News Conference News TCT 2018

ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year

Yael L. Maxwell

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

Presentation TCT 2017

Beyond Heparin: When and How to Escalate Therapy for Acute PE (Lytics, Catheter-Based, Surgery)

Presenter: Peter P. Monteleone, Thomas M. Tu, Jay S. Giri

November 01, 2017

Advertisement

What Makes MedTech Great—or Not—and Envisioning Its Future

What’s Going to Be Hot at TCT 2025

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Moving Beyond Pharmacotherapy: The Transformative Role of Devices in HF Treatment

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Failed MitraClip Is Uncommon, but Bleak When It Happens

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Beyond Heparin: When and How to Escalate Therapy for Acute PE (Lytics, Catheter-Based, Surgery)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content